Adjuvant Capital

Adjuvant Capital is a New York-based venture capital firm investing in life science technologies for high-burden global public health challenges. It focuses on neglected and emerging infectious diseases, maternal, newborn and child health, reproductive and sexual health, and nutrition, with an emphasis on low- and middle-income countries. The firm backs biotechnology, pharmaceutical and healthtech companies from early to later-stage venture rounds and has acted as a lead or co-lead investor.